Chiron Taps GSK International Pharma Head Pien For CEO Post
GlaxoSmithKline International Pharmaceuticals President Howard Pien will join Chiron as CEO and president by the end of April
You may also be interested in...
Chiron is turning to former Glaxo Chief Operating Officer Sean Lance to help sharpen its image with investors - and to manage a transition in its relationship with Novartis.
GLAXO U.S. CHIEF OPERATING OFFICER SEARCH IS PRIORITY FOR CEO INGRAM following his elevation to CEO of Glaxo Wellcome, plc. Robert Ingram will retain his position as head of the U.S. operating division of Glaxo (Glaxo Wellcome, Inc.) but will name a COO as soon as possible, the company said Oct. 28. The lack of an immediate successor to handle day-to-day U.S. operations highlights the suddenness of Glaxo's announcement of Ingram's promotion. Another indication of the suddenness of the change is that Ingram made a scheduled Oct. 27 presentation to the Oppenheimer investment conference, one day before the promotion was announced.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011